{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T01:32:18Z","timestamp":1795138338128,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3788-1","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T06:40:39Z","timestamp":1511246439000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5455-252X","authenticated-orcid":false,"given":"Eleni","family":"Gkika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hallauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Kirste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Adebahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Bartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes Philipp","family":"Neeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Brass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca Ligia","family":"Grosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Baptist","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"issue":"12","key":"3788_CR1","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s12094-015-1436-2","volume":"17","author":"M Benavides","year":"2015","unstructured":"Benavides M, Anton A, Gallego J, Gomez MA, Jimenez-Gordo A, La Casta A, Laquente B, Macarulla T, Rodriguez-Mowbray JR, Maurel J. Biliary tract cancers: SEOM clinical guidelines. Clin Transl Oncol. 2015;17(12):982\u20137.","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"3788_CR2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/gutjnl-2011-301748","volume":"61","author":"SA Khan","year":"2012","unstructured":"Khan SA, Davidson BR, Goldin RD, Heaton N, Karani J, Pereira SP, Rosenberg WM, Tait P, Taylor-Robinson SD, Thillainayagam AV, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61(12):1657\u201369.","journal-title":"Gut"},{"issue":"1","key":"3788_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/jso.24093","volume":"113","author":"KA Simo","year":"2016","unstructured":"Simo KA, Halpin LE, McBrier NM, Hessey JA, Baker E, Ross S, Swan RZ, Iannitti DA, Martinie JB. Multimodality treatment of intrahepatic cholangiocarcinoma: a review. J Surg Oncol. 2016;113(1):62\u201383.","journal-title":"J Surg Oncol"},{"issue":"14","key":"3788_CR4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, et al. Cisplatin plus Gemcitabine versus Gemcitabine for Biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"issue":"4","key":"3788_CR5","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00270-010-9849-3","volume":"33","author":"G Carrafiello","year":"2010","unstructured":"Carrafiello G, Lagan\u00e0 D, Cotta E, Mangini M, Fontana F, Bandiera F, Fugazzola C. Radiofrequency ablation of Intrahepatic Cholangiocarcinoma: preliminary experience. Cardiovasc Intervent Radiol. 2010;33(4):835\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"7","key":"3788_CR6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/cncr.25625","volume":"117","author":"MV Kiefer","year":"2011","unstructured":"Kiefer MV, Albert M, McNally M, Robertson M, Sun W, Fraker D, Olthoff K, Christians K, Pappas S, Rilling W, et al. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer. 2011;117(7):1498\u2013505.","journal-title":"Cancer"},{"issue":"2","key":"3788_CR7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1245\/s10434-010-1333-4","volume":"18","author":"SC Schiffman","year":"2011","unstructured":"Schiffman SC, Metzger T, Dubel G, Andrasina T, Kralj I, Tatum C, McMasters KM, Scoggins CR, Martin RCG. Precision hepatic arterial Irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival. Ann Surg Oncol. 2011;18(2):431\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"3788_CR8","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvir.2013.02.031","volume":"24","author":"S Mouli","year":"2013","unstructured":"Mouli S, Memon K, Baker T, Benson Iii AB, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol. 2013;24(8):1227\u201334.","journal-title":"J Vasc Interv Radiol"},{"issue":"4C","key":"3788_CR9","first-page":"3009","volume":"27","author":"A Mambrini","year":"2007","unstructured":"Mambrini A, Guglielmi A, Pacetti P, Iacono C, Torri T, Auci A, Nicoli N, Orlandi M, Guadagni S, Fiorentini G, et al. Capecitabine plus hepatic intra-arterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res. 2007;27(4C):3009\u201313.","journal-title":"Anticancer Res"},{"issue":"1","key":"3788_CR10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-007-0335-4","volume":"12","author":"NS Becker","year":"2008","unstructured":"Becker NS, Rodriguez JA, Barshes NR, O\u2019Mahony CA, Goss JA, Aloia TA. Outcomes analysis for 280 patients with Cholangiocarcinoma treated with liver transplantation over an 18-year period. J Gastrointest Surg. 2008;12(1):117\u201322.","journal-title":"J Gastrointest Surg"},{"key":"3788_CR11","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","volume":"125","author":"ME Ortner","year":"2003","unstructured":"Ortner ME, Caca K, Berr F. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology. 2003;125:1355\u201363.","journal-title":"Gastroenterology."},{"key":"3788_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1200\/JCO.2015.61.3778","volume":"34","author":"R Tao","year":"2015","unstructured":"Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, et al. Ablative radiotherapy doses lead to a substantial prolongation of survival in patients with inoperable Intrahepatic Cholangiocarcinoma: a retrospective dose response analysis. J Clin Oncol Off J Am Soc Clin Oncol. 2015;34:219\u2013226.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol."},{"issue":"5","key":"3788_CR13","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijrobp.2008.03.018","volume":"72","author":"ET Shinohara","year":"2008","unstructured":"Shinohara ET, Mitra N, Guo M, Metz JM. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2008;72(5):1495\u2013501.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3788_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0360-3016(02)02845-6","volume":"53","author":"CH Crane","year":"2002","unstructured":"Crane CH, Macdonald KO, Vauthey JN, Yehuda P, Brown T, Curley S, Wong A, Delclos M, Charnsangavej C, Janjan NA. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys. 2002;53(4):969\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"3788_CR15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00066-014-0714-1","volume":"190","author":"F Sterzing","year":"2014","unstructured":"Sterzing F, Brunner TB, Ernst I, Baus WW, Greve B, Herfarth K, Guckenberger M. Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on stereotactic radiotherapy. Strahlenther Onkol. 2014;190(10):872\u201381.","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"3788_CR16","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bpg.2016.06.003","volume":"30","author":"A Mendez Romero","year":"2016","unstructured":"Mendez Romero A, de Man RA. Stereotactic body radiation therapy for primary and metastatic liver tumors: from technological evolution to improved patient care. Best Pract Res Clin Gastroenterol. 2016;30(4):603\u201316.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"3788_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"key":"3788_CR18","doi-asserted-by":"crossref","unstructured":"Gkika E, Adebahr S, Kirste S, Schimek-Jasch T, Wiehle R, Claus R, Wittel U, Nestle U, Baltas D, Grosu AL, et al. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer. Strahlenther Onkol. 2017:1\u201310.","DOI":"10.1007\/s00066-017-1099-8"},{"issue":"4","key":"3788_CR19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","volume":"18","author":"RD Timmerman","year":"2008","unstructured":"Timmerman RD. An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol. 2008;18(4):215\u201322.","journal-title":"Semin Radiat Oncol"},{"key":"3788_CR20","doi-asserted-by":"crossref","unstructured":"Brunner TB, Nestle U, Adebahr S, Gkika E, Wiehle R, Baltas D, Grosu AL: Simultaneous integrated protection: A new concept for high-precision radiation therapy. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al] 2016;192:886\u2013895.","DOI":"10.1007\/s00066-016-1057-x"},{"issue":"4","key":"3788_CR21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ijrobp.2004.07.691","volume":"60","author":"JF Fowler","year":"2004","unstructured":"Fowler JF, Tome WA, Fenwick JD, Mehta MP. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys. 2004;60(4):1241\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3788_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2010.03.013","volume":"95","author":"F Momm","year":"2010","unstructured":"Momm F, Schubert E, Henne K, Hodapp N, Frommhold H, Harder J, Grosu AL, Becker G. Stereotactic fractionated radiotherapy for Klatskin tumours. Radiother Oncol. 2010;95(1):99\u2013102.","journal-title":"Radiother Oncol"},{"issue":"02","key":"3788_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2167-7964.1000216","volume":"05","author":"S Kirste","year":"2016","unstructured":"Kirste S, Trautsch H. Abdominal stereotactic body radiotherapy: local control and correlation to biologically equivalent dose. OMICS J Radiol. 2016;05(02):1\u20137.","journal-title":"OMICS J Radiol"},{"issue":"4","key":"3788_CR24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bpg.2016.08.003","volume":"30","author":"TB Brunner","year":"2016","unstructured":"Brunner TB, Seufferlein T. Radiation therapy in cholangiocellular carcinomas. Best Pract Res Clin Gastroenterol. 2016;30(4):593\u2013602.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"3","key":"3788_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3857\/roj.2014.32.3.163","volume":"32","author":"DH Jung","year":"2014","unstructured":"Jung DH, Kim MS, Cho CK, Yoo HJ, Jang WI, Seo YS, Paik EK, Kim KB, Han CJ, Kim SB. Outcomes of stereotactic body radiotherapy for unresectable primary or recurrent cholangiocarcinoma. Radiat Oncol J. 2014;32(3):163\u20139.","journal-title":"Radiat Oncol J"},{"key":"3788_CR26","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.adro.2016.10.008","volume":"1","author":"KA Sandler","year":"2016","unstructured":"Sandler KA, Veruttipong D, Agopian VG, Finn RS, Hong JC, Kaldas FM, Sadeghi S, Busuttil RW, Lee P. Stereotactic body radiotherapy (SBRT) for locally advanced Extrahepatic and Intrahepatic Cholangiocarcinoma. Adv Radiat Oncol. 2016;1:237\u2013243.","journal-title":"Adv Radiat Oncol."},{"issue":"1","key":"3788_CR27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.radonc.2009.11.004","volume":"94","author":"N Kopek","year":"2010","unstructured":"Kopek N, Holt MI, Hansen AT, Hoyer M. Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol. 2010;94(1):47\u201352.","journal-title":"Radiother Oncol"},{"issue":"2","key":"3788_CR28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.radonc.2011.05.016","volume":"99","author":"FA Polistina","year":"2011","unstructured":"Polistina FA, Guglielmi R, Baiocchi C, Francescon P, Scalchi P, Febbraro A, Costantin G, Ambrosino G. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiother Oncol. 2011;99(2):120\u20133.","journal-title":"Radiother Oncol"},{"issue":"2","key":"3788_CR29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","volume":"78","author":"KA Goodman","year":"2010","unstructured":"Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G, Gibbs IC, Fisher GA, Koong AC. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys. 2010;78(2):486\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3788_CR30","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.7150\/jca.13032","volume":"6","author":"A Mahadevan","year":"2015","unstructured":"Mahadevan A, Dagoglu N, Mancias J, Raven K, Khwaja K, Tseng JF, Ng K, Enzinger P, Miksad R, Bullock A, et al. Stereotactic body radiotherapy (SBRT) for Intrahepatic and Hilar Cholangiocarcinoma. J Cancer. 2015;6(11):1099\u2013104.","journal-title":"J Cancer"},{"key":"3788_CR31","doi-asserted-by":"crossref","unstructured":"Pollom EL, Alagappan M, Park LS, Whittemore AS, Koong AC, Chang DT. Does radiotherapy still have a role in unresected biliary tract cancer? Cancer Med. 2016;6:129\u2013141.","DOI":"10.1002\/cam4.975"},{"issue":"1","key":"3788_CR32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijrobp.2015.04.016","volume":"93","author":"J Klein","year":"2015","unstructured":"Klein J, Dawson LA, Jiang H, Kim J, Dinniwell R, Brierley J, Wong R, Lockwood G, Ringash J. Prospective longitudinal assessment of quality of life for liver cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2015;93(1):16\u201325.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3788_CR33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.ijrobp.2007.08.058","volume":"70","author":"A Mendez Romero","year":"2008","unstructured":"Mendez Romero A, Wunderink W, van Os RM, Nowak PJ, Heijmen BJ, Nuyttens JJ, Brandwijk RP, Verhoef C, Ijzermans JN, Levendag PC. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys. 2008;70(5):1447\u201352.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"3788_CR34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","volume":"26","author":"RV Tse","year":"2008","unstructured":"Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J, Sherman M, Dawson LA. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol. 2008;26(4):657\u201364.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3788_CR35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/0284186X.2011.652736","volume":"51","author":"RA Ibarra","year":"2012","unstructured":"Ibarra RA, Rojas D, Snyder L, Yao M, Fabien J, Milano M, Katz A, Goodman K, Stephans K, El-Gazzaz G, et al. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012;51(5):575\u201383.","journal-title":"Acta Oncol"},{"issue":"1","key":"3788_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-7-67","volume":"7","author":"BM Barney","year":"2012","unstructured":"Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012;7(1):67.","journal-title":"Radiat Oncol"},{"key":"3788_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.radonc.2016.07.020","volume":"121","author":"AA Weiner","year":"2016","unstructured":"Weiner AA, Olsen J, Ma D, Dyk P, DeWees T, Myerson RJ, Parikh P. Stereotactic body radiotherapy for primary hepatic malignancies - report of a phase I\/II institutional study. Radiother Oncol. 2016;121:79\u201385.","journal-title":"Radiother Oncol."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3788-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T07:43:06Z","timestamp":1570347786000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3788-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3788"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3788-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]},"article-number":"781"}}